Objective. To investigate the molecular mechanism underlying inflammation-related ectopic new bone formation in ankylosing spondylitis (AS).
of osteoinductive Wnt proteins and subsequent bone formation through NF-jB (p65) and JNK/activator protein 1 (c-Jun) signaling pathways. Furthermore, inhibition of either the Wnt/b-catenin or Wnt/protein kinase Cd (PKCd) pathway significantly suppressed new bone formation. The increased expression of Wnt proteins was confirmed in both the modified CIA and PGIS models. A kyphotic and ankylosing phenotype of the spine was seen during long-term observation in the modified CIA model. Inhibition of either the Wnt/b-catenin or Wnt/PKCd signaling pathway significantly reduced the incidence and severity of this phenotype.
Conclusion. Inflammation intensity-dependent expression of osteoinductive Wnt proteins is a key link between inflammation and ectopic new bone formation in AS. Activation of both the canonical Wnt/b-catenin and noncanonical Wnt/PKCd pathways is required for inflammation-induced new bone formation.
Ankylosing spondylitis (AS) is the most common form of spondyloarthritis (SpA). In addition to inflammatory back pain and damage to bone and joint structures, the characteristic ectopic formation of new bone and fusion of spinal segments in the axial skeleton are key contributors to the AS disease burden (1, 2) . Although an increasing number of breakthrough findings on AS etiology and symptom-controlling therapy have been published, the mechanism underlying new bone formation has not been equally emphasized or investigated. Consequently, targeted and effective treatments that prevent ankylosis progression have not yet been developed (1) .
An understanding of the elusive relationship between chronic inflammation and bone formation is critical to develop a treatment strategy for aberrant new bone formation. Magnetic resonance imaging has been used extensively to analyze their correlation. Vertebral syndesmophytes are more likely to develop from inflammatory lesions, supporting the notion of a sequential destructive-constructive relationship between inflammation and bone formation. However, the majority of vertebral syndesmophytes develop at sites with no evidence of previous inflammation, suggesting a certain degree of independence (3) (4) (5) (6) (7) . Contradictory findings have also been reported regarding the outcomes of anti-tumor necrosis factor (anti-TNF) therapy. Most clinical and animal studies have indicated that TNF inhibitor treatment is effective for controlling inflammation-related symptoms but does not prevent the progression of structural changes (7) (8) (9) (10) (11) (12) (13) . In contrast, recent long-term studies conducted over 5-8 years have indicated that anti-TNF therapy might decrease the progression of new bone formation (14) . Nonsteroidal antiinflammatory drugs (NSAIDs) have also been shown to reduce the progression of ankylosis and to counteract the effect of inflammation on disease progression (15, 16) .
Since bone formation requires critical osteogenic molecules and pathways, inflammation/stress-induced activation of osteogenic signaling pathways is considered a logical link between inflammation and new bone formation (17) (18) (19) (20) (21) . BMP, Wnt, and hedgehog signaling pathways have previously been investigated and shown to be involved in spinal fusion in patients with AS (17, 19) . These pathways are activated by either inflammation or mechanical stress (20) .
A link between the Wnt signaling pathway and AS was first reported by Diarra et al, who found that Dkk-1, an inhibitor of the canonical Wnt/b-catenin pathway, was expressed at a lower level in patients with AS than in controls and patients with rheumatoid arthritis (RA) (22) . In a later study by Appel et al, the expression of another Wnt/b-catenin pathway inhibitor, sclerostin, was demonstrated to be decreased in patients with AS, and this molecule was found to be linked to radiographic progression in AS (23) . Since then, accumulating evidence has shown that a low level or dysfunction of Dkk-1 or sclerostin plays a role in new bone formation by enhancing the activity of the canonical Wnt pathway (23) (24) (25) (26) . However, whether Wnt proteins are overexpressed and correlate with the pathogenesis of this disease has not been determined. Wnt proteins participate in complex pathways that are involved in numerous molecular events. It is well known that the b-catenin-dependent canonical Wnt signaling pathway plays a critical role in osteogenesis. Among the noncanonical pathways, the Wnt/retinoic acid receptorrelated orphan nuclear receptor 2, Wnt/p38 MAPK, and Wnt/protein kinase Cd (PKCd) pathways have also been shown to be important for bone formation in a b-cateninindependent manner (27) (28) (29) . However, whether and how these pathways are involved in ectopic new bone formation in AS remain to be clarified.
In this study, we explored the bridging role of Wnt in the correlation between inflammation and new bone formation in patients with AS. The results of the present study might shed more light on the enigma of inflammation-related new bone formation in AS and facilitate the improvement of therapeutic strategies for slowing ankylosis progression. Figure 1 , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40468/abstract), and bone marrow blood were obtained during spinal surgery, which was performed by senior surgeons, and 108 peripheral venous blood samples were collected from outpatient clinical services.
MATERIALS AND METHODS
Cell culture. A preosteoblast cell line, MC3T3-E1 subclone 14, and a monocyte cell line, RAW 264.7, were purchased from ATCC. Rat osteoblasts, human bone marrow stem cells, and human monocytes were isolated, identified, and cultured as previously described (32) (33) (34) (35) (36) . Additional details are provided in the Supplementary Methods.
To induce osteogenesis, different progenitor cells were plated in a 6-well plate at a density of 2 9 10 5 cells/well and cultured for 24 hours. The cells were then switched to osteogenic medium consisting of a-minimum essential medium supplemented with 10% fetal bovine serum (FBS), 50 lg/ml L-ascorbic acid, 0.1 lM dexamethasone, and 10 mM b-glycerophosphate to induce osteogenesis. The medium was changed every 3-4 days (37) .
RAW 264.7 cells were treated with different doses of TNF for different periods of time to generate conditioned medium or with phosphate buffered saline to generate control conditioned medium. Every 2 days medium was collected and replaced with fresh medium. The collected conditioned medium was concentrated (20:1) by centrifugation at 5,000g and 4°C for 30 minutes using a Centricon protein concentrator (Millipore). The concentrated conditioned medium was diluted into fresh medium supplemented with 10% FBS (1:10) and used to induce osteogenesis (2 ml per well of a 6-well plate at a density of 2 9 10 5 /well). The conditioned medium used to induce osteogenesis was generated from RAW 264.7 cells that had been treated with TNF for 14 days.
Real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Total RNA was extracted from cells using TRIzol reagent (Invitrogen), and qRT-PCR was performed to analyze gene expression at the messenger RNA (mRNA) level as previously described (37) Western blot analysis. Cells were lysed in radioimmunoprecipitation assay buffer, total proteins were extracted, and protein concentrations were determined using a bicinchoninic acid assay. Western blotting was performed as previously described (37) (see Supplementary Methods for details). Enzyme-linked immunosorbent assay (ELISA). Cells were stimulated with different concentrations of TNF for different durations. Briefly, the protein levels of Wnts, Dkk-1, and TNF in cell culture supernatants and sera were determined using an ELISA kit according to the recommendations of the manufacturer (HuaMei). The sensitivity of ELISA for all proteins was 10 pg/ml.
Luciferase reporter assay. RAW 264.7 cells were plated at a density of 1 9 10 4 cells/cm 2 and transfected with a mixture of luciferase reporter plasmids (Promega), according to the manufacturer's instructions. Luciferase activity was measured with a Luciferase assay kit (Promega). The data were normalized to Renilla luciferase activity, and relative luciferase units were calculated as the ratio of firefly luciferase activity to Renilla luciferase activity.
Chromatin immunoprecipitation (ChIP) assay. RAW 264.7 cell lysates were analyzed with a ChIP assay kit (Upstate Biotechnology), according to the manufacturer's instructions. Anti-p65 and anti-c-Jun antibodies were used to immunoprecipitate DNA protein complexes, and IgG alone was used as a negative control.
Determination of culture mineralization. Alizarin red staining and Von Kossa's staining were used to determine calcium deposition and calcium phosphate-containing nodules and indicate mineralization as previously described (33, 37) (see Supplementary Methods, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.40468/abstract).
Establishment of animal models. DBA/1 mice and BALB/c mice were purchased from Charles River. Modified collagen-induced arthritis (CIA) was induced as described in the Supplementary Methods. The CIA model used in the present study differed in 3 main features from the standard CIA model, which has been used extensively in studies of RA. First, only male DBA/1 mice were used for induction in the present study, while female mice have been found to be more susceptible to RA. Second, the observation period in the present study was not less than 30 weeks. Finally, we investigated not only peripheral joint remodeling but also spinal morphologic changes. The DBA/1 mouse model of spontaneous arthritis and proteoglycan-induced spondylitis (PGIS) were induced using previously described standard methods (12, 21, 22, (38) (39) (40) ) (see Supplementary Methods for details). The Animal Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University approved all animal experiments.
Micro-computed tomography (micro-CT) analysis and histologic analysis. Lumbar spine (spinal segment including intervertebral disc and adjacent end plates) and hind paw specimens were obtained from mice postmortem and fixed with 4% paraformaldehyde. For micro-CT scanning, specimens were fitted in a cylindrical sample holder and scanned using a Scanco lCT40 scanner set to 55 kVp and 70 lA. For visualization, the segmented data were imported and reconstructed as 3-dimensional images using MicroCT Ray V3.0 software (Scanco Medical). Kyphotic angles were measured using the Cobb angle as previously described (41-44) (see Supplementary Methods) with reliability analysis. Quantification of the Cobb angle was performed only in mice with pathologic kyphosis.
For histologic analysis, specimens were decalcified in 0.5M EDTA (Sigma-Aldrich) at 4°C. Paraffin-embedded sections were stained with hematoxylin and eosin (H&E) to evaluate general structures and with alizarin red to evaluate bone formation. Immunohistochemical analysis of the specimens was conducted using specific antibodies. Tissue sections were quantitated according to the percentage of positive cells as previously described (45) . The proportion of positive cells per visual field was calculated using the number of positive cells as the numerator and the number of total cells as the denominator.
Statistical analysis. Statistical significance was analyzed via one-way analysis of variance with Levene's test for homogeneity of variance, followed by the Bonferroni post hoc test or Dunnett's T3 post hoc test based on the comparison to be made and the statistical indication of each test. P values less than 0.05 were considered significant. Analyses were performed using SPSS software for Windows, version 16.0. Figure 1A ). Wnt3a, Wnt4, Wnt5a, Wnt7b, and Wnt10b were found to be more highly expressed in spinal ligament tissue from patients with latestage AS than patients with degenerative spine diseases ( Figure 1B ). Wnt3a, Wnt4, Wnt5a, Wnt7b, and Wnt10b were found to be expressed at significantly higher levels in sera from patients with early-stage AS with vertebral syndesmophytes, as well as patients with late-stage AS, than in healthy controls, patients with degenerative spine diseases, and patients with early-stage AS without vertebral syndesmophytes ( Figure 1C ). TNF was expressed at significantly higher levels in sera from both patients with early-stage AS and those with late-stage AS than in sera from healthy controls and patients with degenerative spine diseases ( Figure 1C) .
RESULTS

Expression of Wnt proteins in spinal ligaments
TNF induces Wnt expression in a dose-and time-dependent manner. In inflammatory bone diseases, monocytes are recruited and interact with cells of the osteogenic lineage by expressing anabolic and catabolic cytokines in both an autocrine and paracrine manner. To determine whether Wnt expression was induced by inflammatory stimulation, we stimulated a monocyte cell line, RAW 264.7, and human monocytes with TNF. Human monocytes were identified using previously described methods (36) (Supplementary Figure 2 and Supplementary Methods, available on the Arthritis on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40468/abstract), we defined doses of 1 ng/ml and 10 ng/ml TNF as lowintensity inflammatory stimulation and a dose of 50 ng/ml TNF as high-intensity inflammatory stimulation.
TNF efficiently induced Wnt expression at both the mRNA and protein levels on day 7 (Figures 2A and  B) . Based on the results of a subsequent expression profile study, constitutive stimulation with a low-dose of TNF (1 ng/ml or 10 ng/ml, with multiple treatments every 48 hours) resulted in a persistent increase in Wnt expression but no increase in Dkk-1 expression at the mRNA level. In contrast, high-dose (50 ng/ml) or short-term (single treatment for 48 hours) stimulation with TNF resulted in increased Wnt expression in a pulsed manner or had no inductive effect. However, it increased the expression of Dkk-1, which is a well-known suppressor of bone formation ( Figures 2C and D) . Thus, only constitutive lowintensity inflammation induces persistent Wnt expression, while high-intensity inflammation induces expression of the Wnt antagonist Dkk-1.
Conditioned medium from cells constitutively stimulated with a low dose of TNF promotes bone formation in vitro. To clarify the correlation between inflammation and new bone formation, we established an in vitro cell culture system to mimic the inflammatory microenvironment of enthesitis, which contained the key elements of inflammatory bone-forming sites. The model included proinflammatory cells, osteoprogenitor cells, and the critical proinflammatory cytokine TNF. A similar in vitro cell culture system has been used to investigate the inflammatory microenvironment associated with tumorigenesis (46) . We collected conditioned medium from RAW 264.7 cells treated with different doses of TNF for 14 days and then used it to stimulate different types of osteoprogenitors. Nodule formation by human bone mesenchymal stem cells, rat osteoblasts, and the MC3T3-E1 preosteoblast cell line was significantly increased following stimulation with conditioned medium from monocytes constitutively treated with a low dose of TNF. In contrast, conditioned medium from cells constitutively stimulated with a high dose of TNF or stimulated for a short duration did not significantly affect nodule formation ( Figures 3A-F and Supplementary Figure 4) . Similar inductive effects on the expression of osteogenic genes, including RUNX2, Osx, ALP, and OCN, were observed 24 hours after induction ( Figures 3G-I) . These results indicate that only constitutive low-intensity inflammation is osteoinductive.
Essential role of Wnt expression in bone formation induced by conditioned medium from cells stimulated with TNF. To explore whether Wnt proteins played a critical role in osteogenesis induced by TNF-stimulated conditioned medium, Wnt gene expression was knocked down with small interfering RNAs (siRNAs) targeting different Wnts (Supplementary Table 3 Figure 5 , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.40468/abstract), and nodule formation by MC3T3-E1 preosteoblasts was significantly decreased in the presence of conditioned medium from these RAW 264.7 cells stimulated with TNF compared to control conditioned medium ( Figures 3J  and K) . Similar effects on the expression of osteogenic genes were observed 24 hours after induction (Figure 3L) . These results suggest that the osteoinductive effect of conditioned medium from cells stimulated with TNF depends on Wnt proteins. We evaluated the osteoinductive capacity of each Wnt family member and provide the first comparative evidence showing that Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt7b, Wnt10b, Wnt11, and Wnt16b are osteoinductive proteins within an identical experimental system ( Supplementary Figures 6 and 7 , available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.40468/abstract).
Both canonical and noncanonical Wnt signaling pathways are required for bone formation induced by conditioned medium from TNF-stimulated cells. To elucidate the involvement of Wnt pathways in bone formation induced by constitutive low-intensity inflammation, we examined the roles of 2 acknowledged osteogenic pathways, the Wnt/b-catenin and Wnt/PKCd pathways, in osteogenesis using our TNF-stimulated conditioned medium-induced in vitro cell culture system of bone formation. The Wnt/b-catenin pathway inhibitor Dkk-1 and the Wnt/PKCd pathway inhibitor Rottlerin significantly suppressed TNF-stimulated conditioned medium-induced nodule formation by different types of osteoprogenitors. Combined treatment with both inhibitors further decreased nodule formation ( Figures 3M and N) . Similarly, knockdown of b-catenin or PKCd gene expression with siRNAs in osteoprogenitors (Supplementary Figure 5) significantly decreased nodule formation induced by conditioned medium from TNF-stimulated cells. Knockdown of both b-catenin and PKCd resulted in further inhibition of nodule formation ( Figures 3M and N) . Similar inhibitory effects of inhibitors of these pathways on the expression of osteogenic genes were observed 24 hours after induction ( Figure 3O ). These results suggest that activation of both the canonical and noncanonical Wnt signaling pathways is required for inflammation-induced osteogenesis. TNF regulates Wnt expression through the NFjB (p65) and JNK/activator protein 1 (AP-1) (c-Jun) pathways. Wnt expression is regulated by TNF in the setting of inflammation (47) . However, the detailed molecular mechanism and regulatory pathway has not been identified. To further understanding of the molecular mechanism through which TNF regulates Wnt expression, we performed serial promoter analysis studies for the Wnt3a and Wnt5a genes and found p65 and c-Jun binding sites (Figures 4A and B) . ChIP assay confirmed the actual binding of p65 and c-Jun to the promoter regions (Figures 4C and D) . Site-directed mutagenesis significantly decreased TNF-induced promoter transactivity ( Figure 4F) . Inhibition of the NF-jB and JNK/AP-1 pathways with both pharmaceutical inhibitors and target-specific siRNA significantly attenuated the TNF-induced up-regulation of Wnt expression (Figures 4E and G-I Activation of Wnt signaling is required for spinal ectopic new bone formation in vivo. To confirm the role of Wnt signaling in inflammation-related ankylosis, we established modified CIA and PGIS mouse models. We obtained the first evidence of whole-spine morphologic changes after collagen induction ( Figure 5A ). Micro-CT images showed significant spinal kyphosis in the mice with modified CIA 30 weeks after induction compared with controls. The Cobb angle at baseline was 37.46-40.88°. Thus, we defined a kyphotic phenotype with a Cobb angle of >45°as kyphosis. The mean AE SD incidence of kyphosis in these mice at 30 weeks was 35 AE 7%, and the mean AE SD angle of local kyphosis was 71.16 AE 6.23° (Figures 5B and C) . This phenotype is similar to clinical observations of the spines of patients with AS (Figure 5D ). Following treatment with Dkk-1 or Rottlerin, the mean AE SD incidences of kyphosis were significantly reduced to 23 AE 4% and 18 AE 4%, respectively. The mean AE SD kyphotic angles were reduced to 56.28 AE 4.65°and 59.97 AE 2.47°, respectively. Following treatment with both inhibitors, the incidence of kyphosis was further reduced to 13 AE 4%, and the kyphotic angle was reduced to 42.17 AE 1.63°, which were not significantly different from those in the controls (Figures 5B and C) . Reliability testing showed that the measurement was reliable and reproducible (Supplementary Table 4 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley. com/doi/10.1002/art.40468/abstract).
Furthermore, the occurrence of significant bony bridging between vertebrae (spinal ankylosis) was observed in a mean AE SD of 40 AE 7% of the mice with modified CIA (Figures 5E and F) . Following treatment with Dkk-1 or Rottlerin, the mean AE SD incidences were reduced significantly, to 28 AE 4% and 23 AE 4%, respectively. Following treatment with both inhibitors, the incidence was further reduced to 8 AE 4% (Figure 5F ). Similar osteogenic changes were observed in the hind paws (Figure 5E ). New bone formed in the hind paws of a mean AE SD of 63 AE 4% of the mice with modified CIA 30 weeks after induction. Following treatment with Dkk-1 or Rottlerin, the mean AE SD incidence of osteophyte formation was significantly reduced to 43 AE 4% and 38 AE 4%, respectively. In the presence of both inhibitors, the incidence was further reduced to 18 AE 4% ( Figure 5G) . H&E staining showed significant osteophyte formation and complete fusion between vertebrae 30 weeks after induction ( Figure 6A ). Positive immunohistochemical staining for Wnt3a, Wnt5a, and Wnt7b was detected at bone-forming sites from 16 to 30 weeks after induction ( Figures 6B and C) . Following treatment with Dkk-1 or Rottlerin, H&E and alizarin red staining revealed that the fusion was suppressed. Following treatment with both inhibitors, osteophyte formation and fusion were further inhibited ( Figures 6A  and D) . In a comparative analysis, the arthritis severity score in the DBA/1 spontaneous arthritis model indicated a more rapidly progressive but self-limited pattern of inflammation, while the modified CIA model showed a relatively low-grade and long-lasting pattern of inflammation (Supplementary Figure 8 , available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.40468/abstract).
Similarly, in the PGIS model, bony bridging and fusion between vertebrae were observed with micro-CT, H&E staining, and alizarin red staining, and it was significantly reduced by treatment with Dkk-1 and Rottlerin ( Supplementary Figures 9 and 10) . Wnt protein expression in the bone-forming site was confirmed by immunohistochemical staining (Supplementary Figure 9) . These results suggest that activation of Wnt signaling is required for ectopic new bone formation in vivo.
DISCUSSION
In an in vitro study, we made 3 key observations that provide new insights into the molecular mechanism of new bone formation in AS. First, we reported the novel observation of expression of Wnt proteins in the ligaments of patients with AS that were collected during correction surgeries (Figure 1) . Second, using an in vitro cell culture system mimicking the inflammatory microenvironment of bone-forming sites, we found that conditioned medium from monocyte cultures that were 1064 LI ET AL constitutively stimulated with low-dose TNF, but not those stimulated with high-dose TNF or subjected to short-term stimulation with TNF, induced persistent Wnt expression through the NF-jB (p65) and JNK/ AP-1 (c-Jun) pathways, followed by subsequent new bone formation (Figures 2-4) . Third, we provided the first evidence that both the canonical Wnt/b-catenin and noncanonical Wnt/PKCd signaling pathways are required for new bone formation (Figure 3) . Two main theories exist regarding the relationship between inflammation and ectopic new bone formation in AS (13) . One theory postulates that inflammation triggered by unknown stimuli drives a bone catabolic process. Later, when inflammation fluctuates and is intermittently suppressed, the bone catabolic process is replaced by a bone anabolic response characterized by overreactive osteogenesis. The other theory suggests that inflammation and bone formation are uncoupled and that the same triggers independently activate inflammatory and stromal cells. The activation of stromal cells leads to bone formation. The suppression of inflammation might even promote bone formation (the TNF brake hypothesis).
Our in vitro cell culture system might provide a link between these theories by showing that TNF induces the expression of osteogenic Wnt proteins in the inflammatory microenvironment. Autoimmune responses cause inflammation in entheses. The inflammation level fluctuates in response to many factors, including autoantigen exposure, immune cell responsiveness, and local blood supply. When the inflammation level is relatively low at a certain disease stage, low-intensity TNF stimulation induces strong and persistent expression of Wnt proteins at bone-forming sites. Subsequently, Wnt-induced osteogenesis occurs in an inflammation-independent manner. When the inflammation level becomes relatively high, elevated TNF levels induce the expression of numerous cytokines such as Dkk-1 ( Figure 2C ) with catabolic effects on bone structures, overcoming the anabolic effects of the osteogenic molecules. When the inflammation level again decreases, the bone-forming period resumes. Inflammation is an initiating factor and a restricting factor for new bone formation. The catabolic-anabolic cycle is driven by the intensity of inflammation. The osteogenic molecules induced by proinflammatory cytokines represent a key link between inflammation and new bone formation, whereas inflammation intensity is the bone formation switch.
The TNF brake hypothesis was proposed to explain the enhancement of new bone formation following TNF blockade in the clinical setting. Considering our findings, we speculate that the application of an effective anti-TNF treatment significantly decreases the TNF level, but it does not reach the baseline level observed in the normal population. This reduced TNF level no longer exerts an inhibitory effect on bone formation; rather, it increases the expression of osteogenic Wnt proteins and exerts an osteoinductive effect. This finding may explain the TNF brake hypothesis to some extent. However, if NSAIDs and TNF blockers are administered at a very early disease stage and are used for long periods, lowintensity inflammation may be further inhibited, and the inductive effect on osteogenic molecules might be sabotaged. This finding might explain the importance of the therapeutic time window and duration (14) (15) (16) 48, 49) .
One of the complexities of Wnt signaling is that different Wnt proteins seem to have overlapping functions. The Wnt protein family currently comprises 19 members. Previous studies have shown that some members are osteogenic. However, results have varied among studies due to differences in experimental conditions, cell types, stimulation methods and durations, and osteogenesis measurements (27) (28) (29) (50) (51) (52) . We screened all family members in the current culture system using different osteoprogenitor cell types to compare the osteogenic abilities of the Wnt proteins. Wnt3a, Wnt4, Wnt5a, Wnt5b, Wnt7b, Wnt10b, Wnt11, and Wnt16b were found to be osteogenic (Supplementary Figure 6) . To the best of our knowledge, this study provides the first comparison of the osteoinductive effect of different Wnt proteins in the same culture system.
To confirm the role of Wnt signaling in new bone formation, we further conducted an in vivo experiment. Wnt protein expression was observed at bone formation sites ( Figures 6B and C and Supplementary Figure 9 ). Significant spinal ankylosis and obvious kyphosis were observed in mice with modified CIA, which are very similar to the morphologic changes observed in the spine of patients with AS ( Figure 5D ). Inhibition of Wnt signaling was found to significantly suppress new bone formation and kyphosis, indicating a critical role for Wnt signaling in the progression of ankylosis (Figures 5A-C) . A PGIS model was also established, and the key role of Wnt in spinal ankylosis was confirmed in this model (Supplementary Figures 9 and 10 ).
An important and interesting finding of our in vivo experiment that has not been described previously was the spinal ankylosis and kyphosis observed during the late stage of the disease in the modified CIA model. Four non-transgenic models are most frequently used to study bone and joint pathology in rheumatic diseases: spontaneous arthritis in DBA/1 mice, CIA, collagen antibodyinduced arthritis, and proteoglycan-induced arthritis/ PGIS. In all of these models, bone remodeling and new bone formation were found to be closely correlated to the inflammation process (12, 13, (20) (21) (22) (53) (54) (55) (56) . Of these models, osteophytes in the paws of DBA/1 mice and syndesmophytes leading to vertebral bony bridging in the PGIS model are most widely considered to be pathologic changes similar to new bone formation in the axial skeleton of patients with AS. Spinal syndesmophytes and fusion have only been shown to develop in the PGIS model in the existing literature (20, 21, 40, (57) (58) (59) .
Our novel finding of spinal fusion in mice with modified CIA might be due to 2 factors. First, low-intensity constitutive inflammation might be the important driving factor for osteogenesis. Previously, data from animals with CIA were obtained over periods of no longer than 70 days after the last induction; thus, potential subsequent changes in the spine have not been reported (60) (61) (62) (63) (64) . In this study, we extended the observational period to 30 weeks and found that spinal changes began at week 16 and that 40% of the experimental animals had spinal ankylosis at week 30 after induction (Figures 5A-C) . In our comparative analysis, in DBA/1 mice with spontaneous arthritis, which had no spinal involvement, the inflammation level reached a peak level more rapidly and decreased to almost the baseline level after [16] [17] [18] weeks. This finding is consistent with the major evidence showing that arthritis in this model is a self-limited process and ceases within 8-12 weeks after onset (65) . In contrast, the mice with modified CIA more slowly reached a lower peak level of inflammation and then presented a relatively persistent inflammation level for up to 30 weeks (Supplementary Figure 8 ). Although a direct comparison of inflammation severity may not be the most appropriate due to the great heterogeneity of the DBA/1 model (different time of onset, peak inflammation level, duration of the peak inflammation level, and duration of the whole disease process among different studies) (65) (66) (67) (68) (69) (70) , it at least supported the notion that spontaneous arthritis in DBA/1 mice presents a self-limited and unstable pattern of inflammation, whereas mice with CIA present with a relatively long-lasting and stable pattern of inflammation. These findings indicate that inflammation-induced osteogenesis depends on a certain intensity of constitutive inflammatory stimulation. Second, type II collagen in the intervertebral disc might be a key autoimmune target in the spine. Type II collagen is abundantly expressed in articular cartilage. However, in the spine, type II collagen is mainly expressed at high levels in the disc, which is basically an avascular tissue. Only blood vessel infiltration into a chronically inflamed and degenerative disc results in the exposure of type II collagen, which becomes a local autoantigen and autoimmune target that is reactivated by collagen or PG induction (40, 59) . The phenomenon of ankylosis and subsequent bone formation observed in the PGIS model and our long-term modified CIA model suggests that enthesitis and discs are important sites of inflammation-related ankylosis.
The present study has some limitations. First, the specific role of each Wnt protein in the ectopic formation of new bone is unclear. Further studies of the specific roles of these proteins would aid the treatment of patients with osteogenesis at different disease stages. Second, we have not clearly determined whether crosstalk occurs between Wnt signaling and other important osteogenic signaling pathways. Third, further investigations are required to determine whether other noncanonical Wnt pathways are also involved in this process. Moreover, whether our findings exist in transgenic mouse models with spinal syndesmophytes, especially HLA-B27-transgenic models (including B27/ hb 2 m-transgenic Lewis rats, B27/hb 2 m-transgenic F344 rats, and B27/hb 2 m-transgenic Lewis rats 21-3 9 283-2 F1), has not been verified in the present study. Further confirmation of our key findings in these models is important to conclude that our findings represent common phenomena in all mouse models with spinal ankylosis.
In summary, the novel findings of this study strongly suggest that inflammation intensity-dependent expression of osteoinductive Wnt proteins is a key link between inflammation and ectopic new bone formation in AS. Activation of both the canonical Wnt/ b-catenin and noncanonical Wnt/PKCd pathways is required for inflammation-induced new bone formation in AS. To translate our findings to therapeutic strategy, pathway complexity must be fully considered when targeting Wnt signaling pathways. The timing and duration of antiinflammatory treatments are of great importance for inhibiting the osteoinductive effect of low-intensity inflammation and preventing the onset and progression of ankylosis. Based on our findings, early, long-term, thorough antiinflammatory therapy is recommended.
